Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia
Open Access
- 1 June 2005
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 64 (6) , 849-853
Abstract
Objectives: Raised levels of the cytokines interleukin (IL) 6 and IL10 have been reported in patients with systemic lupus erythematosus (SLE). Objective: To determine if levels of IL6 and IL10 correlate with organ/system-specific disease activity in SLE, using the British Isles Lupus Assessment Group (BILAG) Disease Activity Index. Methods: Levels of IL6 and IL10 in serum samples from 171 patients with SLE and 50 normal controls were determined by enzyme linked immunosorbent assay (ELISA). Levels of cytokines in individual patients with SLE were compared with the presence or absence of active disease in eight organ/systems using the BILAG index. Results: Levels of IL6 were significantly higher (p = 0.005) in patients with active compared with inactive haematological disease, as scored by the BILAG index. Further analysis showed that this association was dependent on an inverse correlation (p = 0.002, r = −0.26) between IL6 levels and haemoglobin levels in patients with SLE. In contrast, IL10 levels did not correlate with individual organ/system disease activity. Conclusions: Raised levels of IL6 in SLE may influence the development of anaemia in this disease. These findings are in agreement with an increasing number of studies, which support physiological links between IL6 and anaemia. Importantly, with the exception of the haematological system, our studies do not provide evidence of any individual organ/system which would respond to therapeutic manipulation of either IL6 or IL10 levels.Keywords
This publication has 34 references indexed in Scilit:
- Elevated Levels of the 90kDa Heat Shock Protein (hsp90) in SLE Correlate with Levels of IL-6 and Autoantibodies to hsp90Journal of Autoimmunity, 2001
- Interleukin-10 and the Interleukin-10 ReceptorAnnual Review of Immunology, 2001
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- Cytokine-mediated Inhibition of Erythropoietin Synthesis by DexamethasoneJournal of Pharmacy and Pharmacology, 1996
- Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin‐10: Interferon‐γ–secreting cells in the peripheral bloodArthritis & Rheumatism, 1996
- Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein.Journal of Clinical Investigation, 1994
- Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice.Journal of Experimental Medicine, 1994
- In vitro regulation of B cell differentiation by interleukin‐6 and soluble CD23 in systemic lupus erythematosus B cell subpopulations and antigen‐induced normal B cellsArthritis & Rheumatism, 1991
- A new interleukin with pleiotropic activitiesBioEssays, 1988
- Recombinant human B cell stimulatory factor 2 (BSF‐2/IFN‐β2) regulates β‐fibrinogen and albumin mRNA levels in Fao‐9 cellsFEBS Letters, 1987